Vaxart, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $53.8M | $25.2M | $34.8M | $44.0M | $143.7M | $126.9M | $13.5M | $11.5M |
| Accounts Receivable | $14.6M | $5.8M | $3.0M | $20.0K | $71.0K | $334.0K | $3.6M | $1.8M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $136.1M | $68.3M | $45.5M | $99.5M | $169.2M | $128.5M | $17.6M | $14.6M |
| Property, Plant & Equipment | $5.4M | $8.7M | $11.7M | $15.6M | $6.6M | $1.5M | $210.0K | $1.1M |
| Goodwill | $4.5M | $4.5M | $4.5M | $4.5M | $4.5M | $0 | — | — |
| Intangible Assets (Excl. Goodwill) | $2.8M | $3.6M | $4.3M | $5.0M | $10.6M | $15.4M | $17.1M | $19.4M |
| Total Assets | $186.1M | $166.4M | $91.8M | $153.8M | $221.2M | $152.6M | $37.0M | $35.2M |
| Liabilities | ||||||||
| Accounts Payable | $21.5M | $7.0M | $1.6M | $5.5M | $3.9M | $2.1M | $852.0K | $962.0K |
| Total Current Liabilities | $86.8M | $90.9M | $13.7M | $17.9M | $10.8M | $11.8M | $9.2M | $7.5M |
| Long-Term Debt | — | — | — | — | — | — | — | $17.7M |
| Total Liabilities | $98.3M | $107.5M | $34.0M | $43.3M | $33.6M | $29.2M | $24.1M | $24.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-460.2M | $-476.5M | $-409.6M | $-327.1M | $-219.4M | $-148.9M | $-116.7M | $-98.0M |
| Total Stockholders' Equity | $87.8M | $58.9M | $57.8M | $110.6M | $187.5M | $123.4M | $13.0M | $11.2M |